Clover Health Investments (NASDAQ:CLOV) had its price target lowered by analysts at Canaccord Genuity Group Inc. from $4.10 to $3.70. They now have a "buy" rating on the stock.
Clover Health Investments, Corp. - Class A Common stock (CLOV)
Company Research
Source: MarketBeat
Impact Snapshot
Event Time:
CLOV
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CLOV alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CLOV alerts
High impacting Clover Health Investments, Corp. - Class A Common stock news events
Weekly update
A roundup of the hottest topics
CLOV
News
- Clover Health (CLOV): Assessing Valuation as 2026 GAAP Profitability Becomes the Next Potential Turning Point [Yahoo! Finance]Yahoo! Finance
- Clover Health: Smart Money Should Be Accumulating Ahead Of 2026 GAAP Profits [Seeking Alpha]Seeking Alpha
- Clover Health Investments (NASDAQ:CLOV) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.MarketBeat
- Clover Health Investments (NASDAQ:CLOV) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Clover Health to Participate in Upcoming 2025 Citi Global Healthcare ConferenceGlobeNewswire
CLOV
Earnings
- 11/4/25 - In-Line
CLOV
Analyst Actions
- 11/6/25 - Canaccord Genuity
CLOV
Sec Filings
- 11/18/25 - Form 4
- 11/12/25 - Form 4
- 11/12/25 - Form 8-K
- CLOV's page on the SEC website